Yayınlanmış 1 Ocak 2021
| Sürüm v1
Dergi makalesi
Açık
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
Oluşturanlar
- 1. Ege Univ, Dept Pharmaceut Biotechnol, Izmir, Turkey
- 2. Izmir Univ Econ, Fac Engn, Dept Genet & Bioengn, Izmir, Turkey
Açıklama
Background: siRNAs hold a great potential for cancer therapy, however, poor stability in body fluids and low cellular uptake limit their use in the clinic. To enhance the bioavailability of siRNAs in tumors, novel, safe, and effective carriers are needed.
Dosyalar
bib-5198cc96-6754-4505-a3f8-3a1adb0cb997.txt
Dosyalar
(315 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:9c56b9e30d4661313285b39c1951e0dc
|
315 Bytes | Ön İzleme İndir |